ALEC — Alector, Inc.

—
Nasdaq · Health Care · Biotechnology · CIK 1653087 ·
Last close
$2.02
Market Cap
$225.55M
52W High
$3.40
52W Low
$1.09
ADV30
4,827,668
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 3,320,000 — -24,393,000 -22,990,000 202,855,000 59,915,000 212,825,000
Mar 2026 1,046,000 — -24,919,000 -22,930,000 239,916,000 76,962,000 229,534,000
Dec 2025 6,237,000 — -39,566,000 -37,267,000 293,237,000 65,802,000 262,588,000
Sep 2025 3,260,000 — -37,608,000 -34,667,000 335,285,000 76,503,000 277,573,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-158,232,000
Investing CF
$153,208,000
Financing CF
$20,168,000
CapEx
$-170,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.10
As of
2026-08-09

Balance + Analyst (yfinance extras)

Retained Earnings
$-1,017,976,000
Inventory
—
Receivables
—
ST Investments
$112,883,000
EBIT TTM
$-126,486,000
Pretax Income TTM
$-117,556,000
Interest Exp TTM
—
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$13,863,000
EBITDA
$-119,029,000
Free Cash Flow
$-107,252,496
Enterprise Value
$98,905,808
Total Cash
$172,798,000
Total Debt
$32,758,000
Shares Out
111,656,919
Trailing EPS
$-1.09
Book Value
$-0.09
ROE
-385.1%
ROA
-27.6%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 21,045,000 -156,007,000 -142,929,000 293,237,000 262,588,000 30,649,000 -184,031,000
Dec 2024 100,558,000 -144,997,000 -119,049,000 468,303,000 341,503,000 126,800,000 -229,905,000
Dec 2023 97,062,000 -151,740,000 -130,391,000 621,827,000 487,669,000 134,158,000 -184,162,000
Dec 2022 133,617,000 -137,834,000 -133,310,000 787,648,000 573,206,000 214,442,000 -20,329,000

TTM Snapshot

Revenues TTM
$18,417,000
NetIncome TTM
$-125,388,000
OpCashFlow TTM
—
Assets (Latest)
$239,916,000
Forward EPS
$-0.75

Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $2.50 · spot: $2.02 · call volume: 198 · put volume: 2
Expected Move to 2027-04-16: ±$1.37 (67.82%) — implied range $0.65 – $3.39 · ATM straddle on $2.50 strike

Peers — same industry

TickerNameMarket CapLastDaily %
PLX Protalix BioTherapeutics, Inc. $217.54M $2.70 —
IVVD Invivyd, Inc. $206.45M $0.70 —
PALI PALISADE BIO, INC. $252.69M $1.45 —
CGEN COMPUGEN LTD $200.82M $2.12 —
STRO SUTRO BIOPHARMA, INC. $254.02M $15.32 —

News headlines (Yahoo Finance, 1h cache)

Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline
2026-10-07 20:05 · Yahoo
Alector shares up after sealing $1.27bn Roche Parkinson’s disease license deal
2026-10-06 10:59 · Yahoo
Alector Signs $1.27 Billion Genentech License Agreement for Parkinson’s Disease Program
2026-10-05 14:13 · Yahoo
Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drug
2026-10-05 13:57 · Yahoo
Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases
2026-10-05 11:00 · Yahoo
Alector to Participate in Upcoming Healthcare Conferences
2026-09-03 20:05 · Yahoo
Alector Reports Second Quarter 2026 Financial Results and Provides Business Update
2026-08-06 20:05 · Yahoo
GSK ends brain drug alliance with Alector
2026-07-09 11:45 · Yahoo
Alector (ALEC) Stock Faces Mixed Analyst Target Changes On Tau Therapy Readthrough
2026-06-19 00:18 · Yahoo
How The Alector (ALEC) Investment Story Is Shifting With Tau Readthroughs And BBB Shuttle Focus
2026-05-19 04:34 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.